Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Financial Officer | May 15, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 317,930 |
Ending reported balance
After 2026-05-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-15 · Purchase · Acquired 150,000 · Balance 267,930 F1: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.639 to $0.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1). Row 2 · 2026-05-18 · Purchase · Acquired 50,000 · Balance 317,930 F2: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.627 to $0.639, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2). |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.639 to $0.650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1).
F2: The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.627 to $0.639, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2019 Filed Apr 17, 2019 20:33 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,500 | $15.42 | $23,125.05 |
DisclosureSEC source: 0001209191-19-024993 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,664 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. Read SEC document |
| March 29, 2019 Filed Mar 29, 2019 20:50 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 819 | $16.52 | $13,529.88 |
DisclosureSEC source: 0001209191-19-021782 · doc4.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,164 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.62, inclusive. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 20:50 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 831 | $16.30 | $13,545.30 |
DisclosureSEC source: 0001209191-19-021782 · doc4.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,983 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.04 to $16.42, inclusive. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 20:50 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 855 | $15.84 | $13,543.20 |
DisclosureSEC source: 0001209191-19-021782 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,814 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.82 to $15.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 26, 2019 Filed Mar 26, 2019 20:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 863 | $15.68 | $13,531.84 |
DisclosureSEC source: 0001209191-19-021335 · doc4.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,669 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.68 to $15.83, inclusive. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 20:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 887 | $15.26 | $13,535.62 |
DisclosureSEC source: 0001209191-19-021335 · doc4.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,532 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.12 to $15.40, inclusive. Read SEC document |
| March 22, 2019 Filed Mar 26, 2019 20:43 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 866 | $15.65 | $13,552.90 |
DisclosureSEC source: 0001209191-19-021335 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,419 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.41 to $15.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 21:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 850 | $15.92 | $13,532.00 |
DisclosureSEC source: 0001209191-19-020805 · doc4.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,285 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.89 to $16.0901, inclusive. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 21:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 870 | $15.56 | $13,537.20 |
DisclosureSEC source: 0001209191-19-020805 · doc4.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,135 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.56 to $15.63, inclusive. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 21:15 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 864 | $15.68 | $13,547.52 |
DisclosureSEC source: 0001209191-19-020805 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,005 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.61 to $15.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 18, 2019 Filed Mar 18, 2019 21:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 871 | $15.54 | $13,535.34 |
DisclosureSEC source: 0001209191-19-020034 · doc4.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,869 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.54 to $15.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 21:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 879 | $15.39 | $13,527.81 |
DisclosureSEC source: 0001209191-19-020034 · doc4.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,740 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.34 to $15.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 21:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 884 | $15.32 | $13,542.88 |
DisclosureSEC source: 0001209191-19-020034 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,619 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.30 to $15.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2019 Filed Mar 13, 2019 22:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 859 | $15.75 | $13,529.25 |
DisclosureSEC source: 0001209191-19-019214 · doc4.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,503 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.66 to $15.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 12, 2019 Filed Mar 13, 2019 22:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 846 | $15.99 | $13,527.54 |
DisclosureSEC source: 0001209191-19-019214 · doc4.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,362 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.83 to $16.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 22:02 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 849 | $15.95 | $13,541.55 |
DisclosureSEC source: 0001209191-19-019214 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,208 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.87 to $16.0835, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 22:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 14,047 | $13.33 | $187,246.51 |
DisclosureSEC source: 0001209191-18-062262 · doc4.xml · nonDerivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,057 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.17 - $13.63, inclusive. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-062262 · doc4.xml · derivative · entry 4 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock. F6 · derivative.exercise_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). F6 · derivative.expiration_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 13,100 | $13.69 | $179,339.00 |
DisclosureSEC source: 0001209191-18-062262 · doc4.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,104 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.30 - $14.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5) to this Form 4. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 22:20 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 75,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-062262 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock. F2 · balance_after: Includes 1,043 shares of the Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 05, 2018 Filed Dec 7, 2018 21:51 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061532 · doc4.xml · derivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of share of the Issuer's Common Stock. F2 · derivative.exercise_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). The PSUs have not yet settled. F2 · derivative.expiration_date: The performance stock units ("PSUs") vested upon the Compensation Committee of the Issuer's Board of Directors certifying that at least 85,000,000 customers or accounts of the Issuer's financial institution ("FI") partners had logged in and visited the online or mobile banking applications of the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, or opened an email from the Issuer's FI partners featuring the Issuer's Cardlytics Direct product, during a monthly period ("MAUs"). The PSUs have not yet settled. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 20:11 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,198 | $20.66 | $24,750.68 |
DisclosureSEC source: 0001209191-18-047737 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,161 F1 · kind: Represents shares sold to cover taxes due upon the settlement of certain restricted stock unit grants. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 3,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · derivative · entry 9 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,859 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 1,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · derivative · entry 8 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 Underlying: Common Stock · 1,193 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 1,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · derivative · entry 7 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series G' Redeemable Convertible Preferred Stock · 1,193 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock. F4 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering. F4 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 2,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · derivative · entry 6 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,666 Underlying: Common Stock · 2,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 2,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · derivative · entry 5 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series G' Redeemable Convertible Preferred Stock · 2,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock. F4 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering. F4 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionSeries G' Redeemable Convertible Preferred Stock · Derivative | 621 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · derivative · entry 4 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621 Underlying: Common Stock · 621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionRestricted Stock Unit · Derivative | 621 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · derivative · entry 3 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Series G' Redeemable Convertible Preferred Stock · 621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock. F4 · derivative.exercise_date: The RSUs vested upon the completion of the Issuer's initial public offering. F4 · derivative.expiration_date: The RSUs vested upon the completion of the Issuer's initial public offering. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | PurchaseCommon Stock | 1,500 | $13.00 | $19,500.00 |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · nonDerivative · entry 2 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,359 F2 · kind: Represents shares purchased through the Issuer's directed share program in connection with its initial public offering. Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 21:18 UTC | Cardlytics, Inc. CDLX · Entity 7603 | ConversionCommon Stock | 3,859 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-010381 · doc4.xml · nonDerivative · entry 1 Evans David Thomas · CIK 0001730451 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series G' Redeemable Convertible Preferred Stock converted into the Issuer's Common Stock on a one-for-one basis upon the Issuer's initial public offering and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.